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Innate lymphocytes have recently received a lot of attention. However, there are different
ideas about the definition of what is “innate” in lymphocytes. Lymphocytes without V(D)J-
rearranged antigen receptors are now termed innate lymphoid cells (ILCs) and include
cells formerly known as natural killer (NK) cells. Also, lymphocytes that are innate should
be able to recognize microbial or stress-induced patterns and react rapidly without prior
sensitization, as opposed to adaptive immune responses. Formally, genuine innate lym-
phocytes would be present before or at birth. Here, we review the ontogeny of human
and mouse innate T lymphocyte populations. We focus on γδ T cells, which are prototype
lymphocytes that often use their V(D)J rearrangement machinery to generate genetically
encoded predetermined recombinations of antigen receptors. We make parallels between
the development of γδ T cells with that of innate αβ T cells [invariant (i)NKT and mucosa-
associated invariantT cells] and compare this with the ontogeny of innate B cells and ILCs
(including NK cells). We conclude that some subsets are more innate than others, i.e.,
innate lymphocytes that are made primarily early in utero during gestation while others are
made after birth. In practice, a ranking of innateness by ontogeny has implications for the
reconstitution of innate lymphocyte subsets after hematopoietic stem cell transplantation.
Keywords:T cell, gammadeltaT cells, ILC, fetal, neonatal, HSCT, BTN3A1, Skint1
INTRODUCTION
Immune responses are traditionally classified into two types:
innate and adaptive. In textbooks, immune cells are usually
assigned to one of these arms of the immune system, for exam-
ple, neutrophils and macrophages in the innate arm and con-
ventional T cells, restricted by MHC molecules, in the adaptive
arm. Innate lymphocytes, however, can rearrange clonal antigen
receptor loci [T cell antigen receptor (TCR) or B cell antigen
receptor (BCR)] but at the same time show characteristics of the
innate immune system: recognition of molecular patterns, rapid
response, and no need for clonal expansion. In addition, there are
lymphocytes not expressing a TCR or BCR, including the natural
killer (NK) cells with “NK activity” that were discovered 40 years
ago (1, 2). More recently, the family of non-T/non-B cells has
been extended to include a series of other innate lymphocytes
collectively called “innate lymphoid cells (ILCs)” (3). However,
the boundaries between lymphocytes of the innate and adap-
tive immune system are blurred. On the one hand, non-T/non-B
innate lymphocytes such as NK cells can adapt to their envi-
ronment (4) and even possess memory characteristics after viral
infection (5–7), reviewed in Ref. (8–10). On the other hand, T and
B lymphocytes that undergo V(D)J recombination to rearrange
their antigen receptor loci can be innate lymphocytes as well:
within T cells one has αβ TCR-expressing T cells of which the
TCR does not recognize MHC/peptide complexes [invariant NKT
(iNKT) cells and mucosa-associated invariant T cells (MAIT) (11,
12) and T cells expressing γδ TCRs (13, 14)], within B cells one
has B1 and marginal zone (MZ) B lymphocytes (15, 16).
Literally, “innate lymphocytes” would implicate that these cells
are generated before birth and that their presence would not
depend on environmental cues. In this review, emphasis will be
given to the ontogeny of the different types of innate lymphocytes
in humans and mice. In both organisms, some subsets of innate
lymphocytes are generated mainly during fetal life, while others
are made later in life. The timing of innate lymphocyte gener-
ation could depend on the stem cells of which they are derived
from and/or the specific fetal environment. This knowledge can be
important in clinical settings, for example, to have insight into the
reconstitution of innate-like lymphocytes during hematopoietic
stem cell transplantation (HSCT).
INNATE-LIKE T LYMPHOCYTES
γδ T CELLS
Like conventional αβ T cells and B cells, γδ T cells use V(D)J
gene rearrangement with the potential to generate a set of highly
diverse receptors to recognize antigens. This diversity is mainly
generated in the complementary-determining region 3 (CDR3)
encoded within the TCR or BCR loci (14, 17). The tripartite sub-
division of lymphocytes possessing rearranged receptors into B
cells, αβ T cells, and γδ T cells has been conserved since the emer-
gence of jawed vertebrates, more than 450 million years ago (18),
and may even originate from earlier evolutionary events (19). A
major difference between αβ T cells and γδ T cells is the way they
recognize antigens. In contrast to conventional αβ T cells, γδ T
cells are not dependent on classical MHC molecules presenting
peptides. Based on the ligands that have been identified, it appears
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that γδ TCRs can recognize antigens in an antibody-like fashion,
while the TCR of other γδ T cell subsets can bind to the MHC-
like protein CD1d loaded with lipids (13, 20–25). Although there
are common characteristics among γδ T cells, it is clear that γδ
T cells, analogous to αβ T cells, do not represent a homogenous
population of cells with a single physiological role (26). γδ T cells
are typically grouped according to the type of Vγ chain (in mice)
or Vδ chain (in humans) they express. Of note, their TCR recom-
bination machinery is often used to generate always the same γδ
TCRs of rather limited diversity and the expression of the respec-
tive invariant γδTCR recombinations is often associated with their
anatomical location and/or function (14, 27, 28).
Human γδ T cells
In humans, the two prevailing subsets of γδ T cells are character-
ized as Vδ2-positive (Vδ2+) and Vδ2-negative (Vδ2–) γδ T cells.
The former expresses the TCR variable (V) region pair Vγ9Vδ2
(main subset in adult peripheral blood) and the latter expresses
Vδ1 paired with various Vγ elements (enriched in tissues such
as adult gut and liver). The Vγ9Vδ2 subset has been shown to
react specifically toward non-peptide low molecular weight phos-
phorylated metabolites (so-called phosphoantigens) derived from
the isoprenoid metabolic pathway (29). These phosphoantigens
can be microbial-derived – (E)-4-hydroxy-3-methyl-but-2-enyl
pyrophosphate (HMB-PP), derived from the microbe-specific 2-
C-methyl-d-erythritol 4-phosphate (MEP) pathway of isoprenoid
metabolism is the most potent phosphoantigen described- or host-
derived such as isopentenyl pyrophosphate (IPP) (29). Recently,
the butyrophilin BTN3A1 has been shown to be involved in sens-
ing or presentation of these phosphoantigens (30–32) (Figure 1A).
Butyrophilins belong to the immunoglobulin superfamily, and the
subfamily BTN3A contains three different members: BTN3A1,
BTN3A2, and BTN3A3 (30–33). Each subfamily member con-
tains an extracellular N-terminal IgV and a membrane-proximal
IgC domain connected to a single-pass transmembrane domain.
BTN3A1 and BTN3A3 both contain an intracellular B30.2 domain,
which is missing in BTN3A2 (Figure 1A). As recently discussed at
the 6th International Gamma Delta T-Cell Conference in Chicago
(May 16–18, 2014), it is not conclusively established how bind-
ing of phosphoantigen induces allosteric conformational changes
of BTN3A1 and how this leads to activation of Vγ9Vδ2 T cells.
However, it is conceivable that additional molecules are involved
(34) (represented by “X” in Figure 1A). While phosphoantigen-
reactive Vγ9Vδ2 T cells are thought to be restricted to primates,
there is recent evidence that Vγ9, Vδ2, and BTN3A1 genes are co-
conserved across a variety of vertebrate species including primates,
alpaca, armadillo, sloth, dolphin, dromedary, orca, but not rodents
(35).
Although human circulating T cells can be detected as early as
12.5 weeks of gestation, most information on T cells in early life,
including γδ T cells, is derived from studies on cord blood at term
delivery (>37 weeks of gestation) (36). In contrast to adult periph-
eral blood γδT cells, human neonatal cord blood γδT cells express
diverse Vγ and Vδ chains paired in a variety of combinations (37,
38). Thus, the adult-like Vγ9Vδ2 subpopulation only represents
a small fraction of the neonatal γδ T cells at term delivery; the
major fraction are rather Vγ9–Vδ1+ cells (37–41). The current
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FIGURE 1 | (A) Schematic representation of the structures of the super
immunoglobulin family members BTN3A1 (human) and Skint1 (mouse)
(possibly) implicated in the selection of human Vγ9Vδ2 and mouse Vγ5Vδ1 T
cells, respectively. Note the three transmembrane domains in Skint1, while
there is only one for BTN3A1. Both for BTN3A1 and for Skint1, interaction
partners have been suggested to exist (illustrated by the green molecule
“X”), that could be the actual ligands of the Vγ9Vδ2 and Vγ5Vδ1 TCR. The
yellow star in BTN3A1 illustrates the one amino acid difference with the
BTN3A3 B30.2 (histidine instead of arginine at position 351). BTN3A2, the
third member of the BTN3A subfamily, lacks completely the intracellular
domain B30.2. The orange star in Skint1 illustrates a spontaneous mutation
found in FVB mice from Taconic changing the glutamate toward a stop
codon at amino acid position 325. Phosphoantigens (IPP/HMB-PP, red dots)
are proposed to be presented extracellularly by the IgV domain or sensed
intracellularly by the B30.2 domain. (B) Illustration of thymic production,
persistence, and export of human and mouse γδT cell subsets before,
around, and after birth.
picture is that the predominance of the Vγ9Vδ2 subset in adult
blood is due to post-natal expansion of cells expressing particular
CDR3 in response to encounter with microbes, especially those
generating phosphoantigens derived from the microbe-specific
MEP pathway of isoprenoid synthesis (27, 39, 42–44) (Figure 1B).
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Furthermore, this subset has been shown to differentiate rapidly
after birth within the first year of life (45). This view is consistent
with recent deep sequencing studies that found a limited diversity
in the adult TRG (T cell receptor gamma) repertoire. There, the
TRG repertoire of peripheral blood γδ T cells from three indepen-
dent donors was dominated by canonicalVγ9JγP sequences,which
made up to 45% of all amplified TRG sequences (46). Cord blood
γδT cells can produce already significant amounts of IFN-γ after a
brief polyclonal stimulation (38, 45, 47). Emphasizing the acquisi-
tion of functional competence in utero, IFN-γ was produced by γδ
T cells sampled from premature births, and, although 1 month’s
post-partum environmental exposure invariably increased their
TNF-α production, it had no consistent effect on IFN-γ (47).
To investigate whether the human fetus could produce particu-
lar “fetal-type” of γδ T cells, we recently investigated γδ subsets in
human fetal blood before birth. Surprisingly, rather than requir-
ing post-natal microbial exposure, Vγ9Vδ2 T cells turned out to
be the predominant blood subset in the second trimester fetus and
expressed a semi-invariant TCR (48). This population is later on
replaced by otherγδT cell subsets so thatVδ1+ T cells predominate
at birth (Figure 1B). Combined with a low level or absence of the
Vδ2 chain in post-natal thymi (39, 49, 50), our observations point
toward a fetal wave of blood Vγ9Vδ2 production before 30 weeks
of gestation (Figure 1B). Thus, it appears that human Vδ2+ T cells,
and in particular Vγ9Vδ2 T cells with canonical Vγ9JγP sequences
(51), are more innate than Vδ2− (Vδ1+ and Vδ3+) T cells.
Mouse γδ T cells
γδ T cells are the first T cells that leave the thymus in mice.
Those primary T cells are mainly innate γδ T cells that use
their TCR recombination machinery to generate always the same
γδ TCRs with no or little junctional diversity (14, 27). Specif-
ically, the first specialized γδ T cell population, called den-
dritic epidermal T cells (DETCs), is exclusively generated before
birth (Figure 1B). It migrates to and populates the mouse skin
epidermis already in utero. It has a fixed TCR composed of
invariant Vγ5Jγ1Cγ1 and invariant Vδ1Dδ2Jδ2 (Vγ5Vδ1 TCR in
short) without P- or N-nucleotides (52, 53). The same canonical
Vδ1Dδ2Jδ2 chain is employed in combination with an invariant
Vγ6Jγ1Cγ1 TCR chain in IL-17-producing Vγ6Vδ1 T cells. The
development of Vγ6Vδ1 cells is also confined to the embryonic
thymus (Figure 1B). Vγ6Vδ1 cells were initially thought to be
restricted to uterus and tongue (54) but subsequently also found
in many other tissues such as lung (55), liver (56), dermis (57, 58),
secondary lymphoid organs (59), and intestinal lamina propria
(60). Next, IL-4 producing Vγ1+ γδ NKT cells with restricted
Vδ6Dδ2Jδ1 junctions and semi-invariant Vγ1Jγ4Cγ4 junctions
develop perinatally and preferentially localize in liver and spleen
(61–63) (Figure 1B). In contrast, γδ T cells circulating in blood
and secondary lymphoid organs mostly contain either Vγ1 or
Vγ4 rearrangements. These are also produced after birth and are
thought to have highly diverse TCR repertoires (27, 28, 54, 64,
65). In particular, the pool of peripheral Vγ4+ T cells is het-
erogeneous and contains both innate IL-17-producing cells and
cells that are rather biased to IFN-γ production. These can be
segregated according to a CCR6+CD27− and CCR6–CD27+ sur-
face marker phenotype, respectively (66–68). In addition, Vγ4+ T
cells also comprise CD27+CD45RBhigh cells, a subset that read-
ily produces IFN-γ upon stimulation with IL-18 and IL-12 (69).
Furthermore, the requirements for final differentiation of Vγ4+
and other T cells into effector γδ T cells may vary between γδ
T cell types depending on their ontogeny (70). For example, it
was recently proposed that Vγ4+ T cells but not Vγ6+ T cells
require extrathymic environment for imprinting of skin-homing
properties and acquisition of an IL-17-producing phenotype (71).
Selection and peripheral activation of γδ T cells
The above described characteristics of mouse and human γδ
T cells [fetal wave of production, (semi-) invariant TCR, pre-
programing for production of IFN-γ or IL-17] have been linked
in the mouse to the action of selecting elements, most notably
Skint1, an immunoglobulin superfamily member, that selects the
murine intraepidermal Vγ5Vδ1 T cell repertoire (13, 66, 72, 73)
(Figure 1A). The possibility exists that the butyrophilin BTN3A1
may act as a selecting element for Vγ9Vδ2 T cells (Table 1), given
its role in mediating stimulation by phosphoantigens, and its strik-
ing homology to Skint1, so far the only known natural selecting
element for γδ T cells (13, 30–32, 73–75) (Figure 1A). This would
establish a much stronger parallel between human and murine
γδ T cells than is usually articulated, as phosphoantigen-reactive
Vγ9Vδ2 T cells are described to be restricted to primates. Other
parallels between human Vγ9Vδ2 and mouse Vγ5Vδ1 cells are that
both the Vγ5 (TRGV5) and the Vγ9 (TRGV9) gene segments are
the most downstream located (and thus closest to the Cγ1 gene
segment) within the TRG gene cluster (76). In the mouse, this
localization has been shown to contribute to early production of
Vγ5Vδ1 cells (77). Of all human V δ gene segments, V δ2 (TRVD2)
shows the highest similarity to mouse V δ1 (TRVD1): they are the
only two members of a separate cluster in a dendogram com-
paring all V δ and Vα gene segments of human and mouse (78).
Thus, different species may produce different variations of early γδ
T cells according to their specific needs (such as phosphoantigen-
reactive cells in humans and skin-homing cells in mice),but similar
mechanisms may be used to achieve this (Figure 1).
Responses of human γδ T cells in early life infections have been
investigated recently. Placental malaria, which can produce phos-
phoantigens via the MEP pathway, has been shown to alter the
Vγ9 repertoire and to slightly increase the percentage of central-
memory Vγ9Vδ2 T cells (85). Other γδ T cells subsets, such as a
public/invariant Vγ8Vδ1 TCR-expressing subset, have been shown
to be involved in responses to congenital CMV infection (38) [see
“Immune response to Cytomegalovirus in Early Life” within this
Research Topic for further details (Huygens et al. under review)].
Thus, it appears that depending on the type of pathogen infecting
the fetus, different types of γδ T cell subsets react.
Regeneration of γδ T cells in adults
Of note, recent studies have shown that adult HSCT and umbilical
cord blood transplantation (UCBT) result in the appearance of
γδ T cells in the blood of these patients (79, 86). These γδ T cells
were mainly from a different type than the Vγ9Vδ2 T cell subset,
and a major influence of CMV on these non-Vγ9Vδ2 T cells was
observed. Vγ9Vδ2 T cells failed to reach the median of the normal
range during a 2-year follow-up (79), which might indicate that
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adult bone-marrow or peripheral blood derived hematopoietic
stem cells have only a low capacity in generating innate Vγ9Vδ2 T
cells (Table 1). This would need further investigation, as until now
it is even not clear to what extent the γδ T cells observed in the
circulation upon reconstitution are derived from hematopoietic
stem cells or rather from pre-existing γδ T cells in the transplant.
In the mouse model, γδ T cells are efficiently regenerated after
HSCT (59, 87). Furthermore, the Indu–Rag1 mouse model, in
which deficient V(D)J recombination can be repaired by inversion
of Rag1 in the adult stage via tamoxifen-induced cre recombinase
expression (88), showed that γδ T cells can be restored within
2 weeks in adult mice (59). This includes efficient regeneration of
a prominent population of intestinal epithelial Vγ7+ T cells (γδ
iIELs). However, some γδ T cell populations are more innate than
others because they depend on the fetal thymic microenvironment,
on fetal stem cells, or both and therefore cannot be regenerated in
the adult thymus. These inborn γδ T cells cannot be regenerated
in adult mice (Table 1). They include the invariant Vγ5Vδ1 cells
(DETCs) (80) and IL-17-producing invariant Vγ6Vδ1 T cells (54)
as well as natural IL-17-producing γδ T cells with TCRs composed
of other Vγ segments (70). In future deep sequencing studies, it is
likely that additional public, innate, invariant γδT cell populations
will be discovered.
INVARIANT αβ TCR-EXPRESSING T CELLS: iNKT AND MAIT
The vast majority of αβ T cells are conventional T cells, i.e.,
their TCR recognizes peptides derived from pathogen-derived
proteins in the context of MHC class I or II and their TCR
repertoire is polyclonal. However, there exist also small subpop-
ulations of innate-like αβ TCR-expressing T cells that are not
MHC-restricted and express (semi-) invariant TCRs: iNKT cells
and mucosal-associated invariant T (MAIT) cells.
iNK T cells
Invariant NKT cells express a semi-invariant TCR that recognizes
lipids presented by CD1d, a MHC class I-like molecule, both in
human and mice (11). In human, this TCR consists of an invari-
ant Vα24–Jα18 chain that preferentially combines with Vβ11 and
the ortholog in mouse is an invariant Vα14–Jα18 that combines
with Vβ8/Vβ7/Vβ2. Thus, in contrast to the main γδT cell popula-
tion in human adult peripheral blood, namely the primate specific
Vγ9Vδ2 T cells described above, CD1d-lipid reactive iNKT cells
are conserved both in human and mice. Of note, while the repre-
sentation of iNKT cells in human blood is highly variable (range
from 0.001% till more than 1%), it is clear that in mice iNKT cells
are at least 10 times more frequent (11).
The first iNKT cell ligand identified was an α-branched galac-
tosylceramide (abbreviated as the commonly used term αGalCer),
a lipid compound extracted from the marine sponge Agelas mauri-
tianus. Later, closely related glycosphingolipids that substitute for
lipopolysaccharide (LPS) in the cell wall of Sphingomonas, a Gram-
negative, LPS-negative member of the class of α-proteobacteria,
have been identified as iNKT TCR ligands (11). Because it is
known that extracts from A. mauritianus have different proper-
ties depending on season and location and because these sponges
are often colonized by α-proteobacterial symbionts, particularly
by Sphingomonas, the marine sponge αGalCer may in fact have
originated from bacterial symbionts (11). Also in protozoa and
fungi, iNKT ligands have been identified (89). Thus, like phos-
phoantigens for Vγ9Vδ2 T cells, exogenous iNKT activators can
be found in a variety of pathogens.
More recently, several reports have been published related
to the identity of self-antigens for mouse and/or human iNKT
cells, which has generated some controversy. These self-antigens
could play an important role during the development of iNKT
cells, in the (fetal) thymus or periphery. The following mol-
ecules have been described to be endogenous iNKT ligands:
isoglobotrihexosylceramide (iGb3) (90), lysophosphatidylcholine
(LPC) and lysosphingomelin (LSM) (91), the peroxisome-derived
ether-bonded phosphoethanolamine compounds eLPA and pLPE
(92), and β-glucosylceramide (β-GluCer) (93) (Table 1). Note that
iGb3 is unlikely to play an important role for human iNKT cells as
humans do not express the relevant synthase and are thus unable to
synthesize iGb3 (94). Thus, it is possible that multiple endogenous
iNKT antigens exist in human and mouse, which can be important
during development in the thymus and/or later in the periphery
during infection (93) (Table 1). Thus, as for Vγ9Vδ2 T cells, both
exogenous and endogenous/self-derived activators for iNKT cells
have been identified.
Whereas iNKT cells are present in the human fetal thymus
at higher frequencies at the start of the second trimester, their
representation gradually declines with gestational age, and they
are present at very low frequency in the post-natal thymus (95,
96). This situation is similar to human Vδ2+ T cells and indi-
cates that a relatively large part of the human thymic iNKT cell
output occurs during early fetal development. The selecting ele-
ment CD1d is expressed on thymocytes, and endogenous antigens
(β-GlcCer; pLPE) have been described to be expressed in mouse
thymus (92, 93) (Table 1). Thus in contrast to the selecting ele-
ment of the invariant mouse Vγ5Vδ1 T cells (Skint1), which is
expressed on fetal stroma (74), iNKT cells are rather selected on
CD1d-expressing double-positive (DP) thymocytes (95) (Table 1).
Interestingly, it has been recently suggested that distinct mouse
iNKT cell subsets (making either IL-4, IFN-γ, or IL-17) may be
selected by different selecting self-TCR ligands providing different
TCR signal strengths (97), making parallels with the development
of IFN-γ versus IL-17-producing γδ T cell subsets (66, 72, 73).
iNKT cells can be divided according to their expression of CD4:
CD4+ and CD4− iNKT subsets. In the human fetal thymus, iNKT
cells are largely CD4+, and only a small fraction expresses CD161
(95). In contrast to fetal thymus and term cord blood, a majority
of the iNKT cells in adult blood lack expression of CD4 and are
almost uniformly CD161+. Together with change in the expres-
sion of other markers, this indicates that iNKT cell differentiation
is characterized by gradual loss of CD4 expression and increased
expression of CD161 (95). However, it cannot be excluded that
the CD4− subset may be a separate lineage that is extrathymically
derived or that this subset may develop in the thymus at a later
developmental stage (95), and would be thus “less innate” than
the CD4+ counterpart, though this last possibility is less likely
(96). Differences between human and mouse iNKT cell devel-
opment have been observed: while iNKT progenitors are readily
found in human fetal but not in post-natal thymus, progenitors are
frequent in adult mouse thymus; and both CD4+ and CD4− NK
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T cell progenitors are found in the mouse thymus, whereas only
the CD4+ can be detected in the human fetal thymus (95, 98, 99).
Thus, it seems that in human, iNKT cells are preferentially made
before birth and in mice after birth (Table 1). Coinciding with
this is the observation in a mouse tetanus toxoid (TT) immuniza-
tion model: αGalCer given at the time of primary immunization
on post-natal day 17 (“late neonatal stage”) had a significantly
higher TT-specific IgM response as well as memory IgG response,
while αGalCer given on post-natal day 7 (“early neonatal period”)
resulted in only marginal boosting (81). Also, while a high enrich-
ment of murine iNKT cells is observed in the liver (up to 50% of
hepatic lymphocytes), no such enrichment is observed in neither
the fetal nor adult human liver (100); in human, the highest iNKT
frequencies are found in the omentum (101).
In contrast to a previous report (102), it was shown more
recently that, despite the fact that human thymus and cord blood
iNKT cells in humans were predominantly CD4+, they were
capable of significant cytokine production after stimulation with
PMA/ionomycin, including IFN-γ and TNF-α, illustrating that a
large proportion of CD4+ NKT cells in thymus and cord blood
are functionally competent (103). Also recently, it has been shown
that iNKT cells can mature in the second trimester fetus, especially
in the fetal intestine, thus before post-natal microbial exposure
(100). Indeed, these cells express markers associated with matura-
tion (although percentages of CD4+ iNKT cells are relatively high
compared to adult iNKT cells) and can readily produce IFN-γ and
TNF-α (other cytokines where not investigated) after treatment
with αGalCer (100). Despite indications that human iNKT cells
are mainly generated in the fetal thymus (95), it appears that iNKT
cells are well reconstituted after HSCT and UCBT, with the CD4+
subset appearing before the CD4− subset β (82, 83, 104) (Table 1).
Murine iNKT cells are reconstituted as well at 12 weeks after HSCT
(84) (Table 1).
Mucosa-associated invariant T cells
Mucosa-associated invariant T cells, so-called because of their
enrichment in gut lamina propria, express a semi-invariant
αβ TCR, which recognizes (modified) microbial vitamin B2
(riboflavin) metabolites presented by the MHC class I-like mol-
ecule MR1. Like iNKT cells, these cells are conserved in human
and mice (12, 105, 106). In humans, this TCR consists of Vα7.2–
Jα22 and in mouse of Vα19–Jα33, with two variable amino
acids in the CDR3 V–J junction, and recently is has been shown
by high-throughput sequencing that the CDR3β repertoire of
human MAIT cells is oligoclonal (107). Also recently, it has been
demonstrated that the actual antigens bound to MR1 and recog-
nized by the human MAIT TCR are transitory neo-antigens, 5-
(2-oxoethylideneamino)-6-d-ribitylaminouracil (5-OE-RU) and
5-(2-oxopropylideneamino)-6-d-ribitylaminouracil (5-OP-RU),
formed by a non-enzymatic reaction of the riboflavin metabo-
lite 5-amino-6-d-ribitylaminouracil (5-A-RU) with small mole-
cules, such as glyoxal and methylglyoxal, which are derived from
other metabolic pathways (108) (Table 1). It is not clear whether
endogenous/self-antigens exist that are similar to these microbial-
derived antigens, as is the case for Vγ9Vδ2 T cells and iNKT
cells, and that could play a role in the selection of MAIT cells
(109). Although MAIT cells appear to be relatively rare in mice,
they constitute a very significant population of T cells in humans,
accounting for between 1 and 10% of T cells in peripheral blood.
Thus, on this aspect MAIT cells appear to be the counterpart from
the iNKT cells: MAIT are high in human and low in mice, while
for iNKT, the opposite scenario is the case.
In both mouse and humans, it is generally accepted that MAIT
cells develop in the thymus (105, 110, 111). Based on data using
TCR-transgenic mice, it was shown that MAIT cells can be selected
by MR1 expressed on DP thymocytes (112). This is similar to iNKT
cells (CD1d) (112), but different from the invariant Vγ5Vδ1 T cells
(Skint1) where the selecting element is expressed on the thymic
stroma (74) (Table 1). Human MR1 also has been detected pri-
marily on CD3+ thymocytes (113), suggesting that human MAIT
cells might also be selected by DP thymocytes, similar to what was
described for mouse MAIT cells (112). Human MAIT cells are
rare and immature in the fetal thymus, spleen, and mesenteric
lymph nodes (111). However, maturation (such as the capac-
ity to produce IFN-γ) can take place in fetal mucosal tissues
(most pronounced in the intestine), thus before post-natal micro-
bial exposure (111). While cord blood MAIT cells show a naïve
phenotype, they do show effector capacity (TNF-α production)
in response to Mycobacterium tuberculosis-infected cells (113).
MAIT cells from adult peripheral blood on the other hand show
a memory phenotype and have undergone substantial peripheral
expansion, thus indicating post-natal response after antigen expo-
sure, possibly from bacterial flora (110, 113). This is consistent
with the fact that the accumulation of mouse MAIT cells in the
gut lamina propria requires the presence of microbiota (106). This
contrasts with iNKT cells, where their accumulation in tissues is
not changed in germ-free mice (114).
INNATE-LIKE B LYMPHOCYTES
In addition to T cells, also the B cell compartment possesses innate
members: B1 and MZ B lymphocytes, which are well character-
ized in the mouse model. As innate T lymphocytes, they exhibit
a pre-programed phenotype allowing them to spontaneously
secrete so-called natural antibodies (mostly IgM) and/or rapid
proliferation and differentiation into antibody-secreting cells (also
preferentially of the IgM isotype) upon stimulation with T cell-
independent antigens. Whereas murine B1 lymphocytes locate
essentially in peritoneal and pleural cavities,MZ B lymphocytes are
found principally in the MZ of the spleen. These innate B lympho-
cytes have been the subject of recent reviews (15, 16), and we only
briefly summarize some characteristics here in comparison with
innate T lymphocytes. For example, it has been described that an
invariant BCR of both B1 and MZ B lymphocytes can recognize
lipids, both exogenous (phosphorylcholine attached to bacterial
cell-wall glycolipid components) and endogenous (oxidized low-
density lipoprotein and lipids exposed by apoptotic cells) (115).
Thus, like iNKT cells, innate B lymphocytes can be activated by
both bacterial-derived and endogenous lipids, but without the
need of a presenting element. Although adult bone marrow is
capable to generate these cells, this occurs at a lower efficiency
compared to neonatal or fetal-derived stem cells and thus it seems
that B1 lymphocytes are mainly generated before birth (15, 88,
116). In contrast, mouse MZ B lymphocytes are mainly generated
after birth (16), thus again ranking subsets of innate lymphocytes
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according to their “innateness”: B1 lymphocytes are more innate
than MZ B lymphocytes.
In the human system, it would be interesting to know whether
these innate B lymphocytes, especially the most innate B1 cells, are
reconstituted after HSCT. However, these investigations are com-
plicated because of the lack on a consensus on the clear identifica-
tion of B1 lymphocytes in human. Indeed, recently a population of
cells have been described that show functional similar characteris-
tics as murine B1 lymphocytes (117). However, the identification
of these cells has generated controversy, including the finding that
(part of) these cells might rather be pre-plasmablasts (118, 119).
The candidate human B1 lymphocytes described by Griffin et al.
(117) were present in cord blood and declined with age, indi-
cating their preferential generation before birth as for mouse B1
lymphocytes, but this needs further investigation. In contrast to
mouse MZ lymphocytes, it appears that human MZ B lympho-
cytes are mainly generated in the fetus (16, 120). A similar species
difference exists for iNKT cells, which are also mainly generated
after birth in mice, but before birth in human (Table 1). However,
direct comparison between the mouse and human immune sys-
tem in early life should be done with the notion that in general the
human immune system develops relatively early during gestation
compared to the development in mice. In experiments to investi-
gate immune responses, one therefore usually uses day 7 old mice
to compare immune responses with human neonates (121, 122).
NK CELLS AND OTHER INNATE LYMPHOID CELLS
To segregate them from T cells and B cells, lymphocytes without
antigen receptor rearrangement are collectively termed ILCs (3).
These ILCs include the well-established NK cells, lymphoid tissue
inducer (LTi) cells (123), and a family of developmentally related
ILCs that are effectors and regulators in immunity and in tissue
development and remodeling (124).
Natural killer cells were originally described as a cell subset
capable of rapidly eliminating target cells without the need for
prior sensitization (125). NK cells are important in conferring
protection from viral infections, such as CMV [see also “Immune
Response to Cytomegalovirus in Early Life” within this Research
Topic (Huygens et al. under review)], and in the immunosur-
veillance of transformed cells. NK cell activation is the result of
the integration of signals provided by activation receptors such
as NKG2D, recognizing stress-induced ligands such as MICA in
human and Rae-1 in mice, and inhibitory receptors such as mem-
bers of the killer-cell immunoglobulin-like receptor (KIR) family
in humans and C-type lectin Ly49 family in mice, recognizing the
presence of “self” by binding MHC class I molecules. Besides their
role in balancing NK activity in the periphery, KIR and Ly49 mem-
bers play also an important role in the“education”or“licensing”of
NK cells during their development (126, 127). It has been shown
recently that human fetal NK cells differentiate early in utero and
are highly responsive to cytokines and antibody-mediated stim-
ulation but respond poorly to MHC class I-negative target cells.
Indeed, in contrast to adult NK cells, it appears that expression of
KIRs did not educate fetal NK cells but rendered them hypore-
sponsive to target cells lacking MHC class I (128). This selective
hyporesponsiveness could contribute to fetal–maternal tolerance
in utero. Thus, human NK cells can be made early during gestation,
but they appear to be functionally different than adult NK cells.
It remains to be established whether this reflects different waves
of NK cell development: an early wave of fetal NK cells and post-
natal wave of NK cells. Upon HSCT in human, NK cells appear
to reconstitute well and rapidly, with influence of CMV on their
reconstitution [see also “Immune Response to Cytomegalovirus
in Early Life” within this Research Topic (Huygens et al. under
review)] (129), while other ILC populations appear to reconstitute
more slowly (130).
In contrast to the KIR repertoire on human fetal NK cells, the
Ly49 repertoire on mouse fetal and neonatal NK cells is very
restricted: among the entire murine Ly49 family, Ly49E is the
only member expressed before birth (131). Conversely, whereas
the population of NK cells bearing one or more of the other
Ly49 members progressively increases after birth, the percentage
of Ly49E-expressing cells gradually decreases with almost no adult
NK cells displaying this receptor (131). Fetal liver progenitor cells
were shown to be much more efficient in the generation of Ly49E-
expressing NK cells than adult bone-marrow progenitors (132).
Interestingly, Ly49E is also the only Ly49 member expressed by
Vγ5Vδ1 cells (DETC) (133). Despite this particular fetal expres-
sion pattern, it appears that Ly49E does not play a crucial role in
differentiation and/or function of (fetal) NK cells (134).
Natural killer cells and other ILCs share common precursors
during ontogeny as demonstrated in mouse models. Thereby,
development of all sorts of ILCs depends on common gamma-
chain cytokine signaling (135), in particular via IL-7R and IL-15R
(3, 136), and the expression of the transcription factor helix–loop–
helix inhibitor Id2 (137, 138). In addition, while the basic leucine
zipper transcription factor E4BP4/Nfil3 was initially described as
specifically required for the development and maturation of NK
cells (139, 140), it is emerging very recently that E4BP4/Nfil3 is
also crucial for the development of all other ILC subsets (141,
142). Also recently, two independent studies identified precursors
that were specific for the ILC lineages. A common, IL-7R- and
Id2-expressing progenitor named “CHILP” gives rise to all IL-7R-
expressing, “helper-like” ILC lineages including LTi cells but lacks
potential to differentiate into B and T cells or NK cells (143). In
addition, a precursor termed ILCP, defined by transient expression
of high amounts of the transcription factor PLZF, gives rise to all
ILC lineages except LTi cells but lacks potential to differentiate into
B and T cells or NK cells (144). Importantly, both CHILP and ILCP
were found in fetal liver and adult bone marrow. Also, both precur-
sors reconstituted ILC1, ILC2, and ILC3 lineages upon transfer into
Rag- and IL-7R- deficient recipients (into Rag2-/-Il2rg -/- mice).
Collectively, these transfer experiments advocated that ILC1, ILC2,
and ILC3 populations can be regenerated from ILC precursors in
an adult organism. However, it is currently unclear to what extent
ILC precursors and ILCs are de novo regenerated in the steady
state (Andreas Diefenbach, personal communication). Also, it is
presently not clear how efficiently ILCs as well as CHILP and
ILCP precursors are regenerated after HSCT. In human HSCT,
current protocols to monitor immune recovery do not include
ILCs (145). Moreover, recipient CD45+CD3-RORγt+ ILCs per-
sisted long-term post-HSCT in the intestinal lamina propria of
transplanted mice showing that ILCs are relatively radio-resistant
(146). At the same time, more than 1/3 of the ILCs in recipient
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lamina propria were donor-derived 2 months post-HSCT, suggest-
ing that it is likely that development of ILCs is not restricted to
early ontogeny (146).
CONCLUDING REMARKS AND PERSPECTIVES
After reviewing the ontogeny of innate lymphocytes, it becomes
clear that some subsets (such as mouse Vγ5Vδ1 T cells and B1 lym-
phocytes) are more innate than others (such as ILCs, MAIT, and
MZ B lymphocytes). Overall, the preferential generation of innate
lymphocyte subsets before birth appears to have implications for
their reconstitution after HSCT, but this does not need necessarily
to be the case, as indicated for human iNKT cells (Table 1). Many
innate lymphocytes, in particular the very innate γδ T cell ones,
expand in the periphery and persist as long-lived self-renewing
cells. At the same time, these cells show above-average resistance
to ionizing radiation (57–59, 147). This observation can be a
confounding factor for determining the regeneration potential of
innate lymphocyte populations.
A further common attribute of Vγ9Vδ2 T cells, iNKT cells, and
MAIT cells is that all recognize small metabolites derived from
host cellular or (commensal) microbial metabolism using semi-
invariant TCRs and monomorphic presenting/selecting elements
(Table 1). This contrasts with conventional or mainstream αβ T
cells that use TCRs with highly variable CDR3 regions recognizing
processed peptides from pathogen-derived proteins presented by
polymorphic MHC molecules. These metabolites, together with
their selecting/education element, can play an important role dur-
ing the development of these innate cells. Recently, it has been
shown that the TCR signaling of murine innate-like T lympho-
cytes, such as the IL-17-producing Vγ6Vδ1 subset, is critical for
their development but that this signaling is attenuated in the
periphery where these cells become more responsive to innate-like
signals such as derived from cytokine receptors (69). However,
since this did not apply to iNKT cells, it appears not to be a
general phenomenon for all innate-like T lymphocytes. As dis-
cussed by Wencker et al. (69), by altering their TCR response
mode, subsets of innate-like T cells may resemble ILC (that by
definition lack constraint by a TCR). However, these innate-like
T cells are still different from ILCs as they are not fully aner-
gic to TCR signals and the prerequisite for developmental TCR
signaling may provide a means of “quality control” for lym-
phocytes entering the innate compartment that is not available
for ILCs.
The production of different types of innate lymphocytes before
birth compared to later in life (such as expressing different TCRs as
for γδ T cells, or showing a different “KIR educational response”
for human NK cells), may be the result of a “layered” produc-
tion of immune cells by fetal HSC versus adult HSCs. While
evidence for this exists for some subsets, such as the fetal waves
of murine Vγ5Vδ1 T lymphocytes (80) and B1 lymphocytes (15)
with life-long self-renewal, this still needs to be established for oth-
ers (including human Vγ9Vδ2 T cells and NK cells). Also for other
cells of the immune system, a similar mechanism of fetal waves
appears to be operational: in steady state, most tissue macrophage
populations in mice are derived from embryonic precursors, are
seeded before birth, and can maintain themselves in adults by self-
renewal (148). Also, compared to adult HSC, human fetal HSC
gives rise to a distinct type of conventional CD4 T cells with a bias
toward immune tolerance (149).
Finally, it will be interesting to further investigate whether the
“age” of human stem cells in stem cell transplantation (such as age
of donors, or adult bone marrow/peripheral blood HSCT versus
UCBT) can influence the type of innate lymphocytes that is recon-
stituted. This can have important clinical consequences such as
influence on graft-versus-leukemia effect or post-transplantation
CMV infection [e.g., Ref. (79, 86)].
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